➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Moodys
McKinsey
Harvard Business School
Express Scripts

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

DESOXIMETASONE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for desoximetasone and what is the scope of freedom to operate?

Desoximetasone is the generic ingredient in three branded drugs marketed by Actavis Mid Atlantic, Akorn, Cadila, Cosette, Fougera Pharms, Lupin Atlantis, Perrigo New York, Rising, Taro Pharm Inds Ltd, Altana, Glenmark Generics, Novel Labs Inc, Perrigo Israel, Teligent Pharma Inc, Zydus Pharms, and Taro Pharms, and is included in forty NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Desoximetasone has four patent family members in four countries.

There are seven drug master file entries for desoximetasone. Eighteen suppliers are listed for this compound.

Drug Prices for DESOXIMETASONE

See drug prices for DESOXIMETASONE

Drug Sales Revenue Trends for DESOXIMETASONE

See drug sales revenues for DESOXIMETASONE

Recent Clinical Trials for DESOXIMETASONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Wake Forest University Health SciencesPhase 4
Siriraj HospitalPhase 3
Siriraj clinical research centerPhase 3

See all DESOXIMETASONE clinical trials

Pharmacology for DESOXIMETASONE
Medical Subject Heading (MeSH) Categories for DESOXIMETASONE
Paragraph IV (Patent) Challenges for DESOXIMETASONE
Tradename Dosage Ingredient NDA Submissiondate
TOPICORT SPRAY;TOPICAL desoximetasone 204141 2013-12-18

US Patents and Regulatory Information for DESOXIMETASONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharm Inds Ltd TOPICORT desoximetasone CREAM;TOPICAL 073193-001 Nov 30, 1990 AB RX No Yes   Start Trial   Start Trial   Start Trial
Perrigo New York DESOXIMETASONE desoximetasone CREAM;TOPICAL 076510-001 Jul 1, 2003 AB RX No No   Start Trial   Start Trial   Start Trial
Novel Labs Inc DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 206792-001 May 10, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Baxter
Moodys
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.